Connection

Nicola Clementi to Humans

This is a "connection" page, showing publications Nicola Clementi has written about Humans.
Connection Strength

0.083
  1. Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials. Emerg Microbes Infect. 2021 Dec; 10(1):206-210.
    View in: PubMed
    Score: 0.008
  2. Viral Respiratory Pathogens and Lung Injury. Clin Microbiol Rev. 2021 06 16; 34(3).
    View in: PubMed
    Score: 0.008
  3. Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects. J Med Virol. 2021 04; 93(4):2160-2167.
    View in: PubMed
    Score: 0.007
  4. Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro. Pharmacol Res. 2021 01; 163:105255.
    View in: PubMed
    Score: 0.007
  5. Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital. Clin Chem Lab Med. 2020 08 27; 58(9):1573-1577.
    View in: PubMed
    Score: 0.007
  6. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects. J Virol. 2019 06 01; 93(11).
    View in: PubMed
    Score: 0.007
  7. Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines. J Immunol Res. 2019; 2019:8303648.
    View in: PubMed
    Score: 0.006
  8. Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge. Antiviral Res. 2017 07; 143:48-61.
    View in: PubMed
    Score: 0.006
  9. Role and potential therapeutic use of antibodies against herpetic infections. Clin Microbiol Infect. 2017 Jun; 23(6):381-386.
    View in: PubMed
    Score: 0.006
  10. Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing. Eur J Immunol. 2022 01; 52(1):109-122.
    View in: PubMed
    Score: 0.002
  11. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathog. 2021 09; 17(9):e1009878.
    View in: PubMed
    Score: 0.002
  12. Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects. Clin Chim Acta. 2021 Nov; 522:144-151.
    View in: PubMed
    Score: 0.002
  13. Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021. Virol J. 2021 08 14; 18(1):168.
    View in: PubMed
    Score: 0.002
  14. Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy. Viruses. 2021 07 31; 13(8).
    View in: PubMed
    Score: 0.002
  15. The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review. J Hosp Infect. 2021 Aug; 114:63-78.
    View in: PubMed
    Score: 0.002
  16. Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death. Clin Chem Lab Med. 2021 05 26; 59(6):e247-e250.
    View in: PubMed
    Score: 0.002
  17. A case of psoriatic arthritis triggered by SARS-CoV-2 infection. Rheumatology (Oxford). 2021 01 05; 60(1):e21-e23.
    View in: PubMed
    Score: 0.002
  18. Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic. Viruses. 2020 07 24; 12(8).
    View in: PubMed
    Score: 0.002
  19. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science. 2020 08 07; 369(6504):706-712.
    View in: PubMed
    Score: 0.002
  20. Impact of patients nutritional status on major surgery outcome. Eur Rev Med Pharmacol Sci. 2018 06; 22(11):3524-3533.
    View in: PubMed
    Score: 0.002
  21. Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques. J Immunol. 2009 Aug 15; 183(4):2537-44.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.